Response to Correspondence on "A Diagnostic Performance Study of the 2023 ACR/EULAR Classification Criteria For Antiphospholipid Syndrome (APS) in Cohorts of Patients Presenting with Suspected APS" by Lu et al.
Medha BarbhaiyaStephane ZuilyGuilherme Ribeiro Ramires de JésusD Ware BranchDoruk ErkanPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)